Humacyte (HUMA) Free Cash Flow (2020 - 2026)
Humacyte (HUMA) reported Free Cash Flow of -$25.3 million for Q1 2026, up 12.31% year-over-year from -$22.5 million in Q1 2025, and up 3.22% quarter-over-quarter from -$26.1 million in Q4 2025.
Humacyte (HUMA) Free Cash Flow (2020 - 2026) Analysis & Trends
Humacyte (HUMA) has 7 years of Free Cash Flow data on file, last reported at -$25.3 million in Q1 2026.
- Free Cash Flow for Q1 2026 came in at -$25.3 million, up 12.31% year-over-year; the trailing twelve-month figure through Mar 2026 was -$102.3 million (down 1.56% YoY), and the FY2025 annual result was -$105.9 million, down 6.23% from the prior year.
- Free Cash Flow advanced to -$25.3 million in Q1 2026 per HUMA's latest filing, from -$26.1 million in the prior quarter.
- Over five years, Free Cash Flow peaked at -$13.6 million in Q3 2023 and troughed at -$28.8 million in Q1 2025.
- A 5-year average of -$22.1 million and a median of -$23.0 million in 2023 frame the typical range for Free Cash Flow.
- The sharpest annual moves came in 2022 and 2024: Free Cash Flow jumped 44.74% in 2022, then sank 75.39% in 2024.
- A 5-year view of Free Cash Flow shows it stood at -$18.9 million in 2022, then advanced by 9.19% to -$17.2 million in 2023, then plunged by 55.13% to -$26.6 million in 2024, then grew by 1.87% to -$26.1 million in 2025, then rose by 3.22% to -$25.3 million in 2026.
- Business Quant data shows HUMA's Free Cash Flow at -$25.3 million in Q1 2026, -$26.1 million in Q4 2025, and -$24.0 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Free Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 723,416.35 Bn | 723,416.32 Bn | - | - |
| 2 | Belite Bio | 57,340.00 Bn | 57,340.00 Bn | - | - |
| 3 | Quantum Biopharma | 19,125.08 Bn | 19,125.08 Bn | - | -1.67 Mn |
| 4 | Legend Biotech | 3,262.00 Bn | 3,261.71 Bn | 242.10 Mn | -12.20 Mn |
| 5 | Akari Therapeutics | 1,789.67 Bn | 1,789.67 Bn | - | -2.49 Mn |
| 6 | Evaxion A | 1,480.39 Bn | 1,480.37 Bn | - | - |
| 7 | Psyence Biomedical | 241.78 Bn | 241.78 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 113.54 Bn | 106.29 Bn | 2.59 Bn | 1.29 Bn |
| 9 | Abivax | 94.26 Bn | 94.26 Bn | - | 63,220.27 |
| 10 | Humacyte | 267.09 Mn | 218.55 Mn | -1.54 Mn | -25.28 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -25.28 Mn |
| Mar 31, 2026 | -25.28 Mn |
| Dec 31, 2025 | -26.12 Mn |
| Dec 31, 2025 | -26.12 Mn |
| Sep 30, 2025 | -23.95 Mn |
| Sep 30, 2025 | -23.95 Mn |
| Jun 30, 2025 | -26.98 Mn |
| Jun 30, 2025 | -26.98 Mn |
| Mar 31, 2025 | -28.83 Mn |
| Mar 31, 2025 | -28.83 Mn |
| Dec 31, 2024 | -26.62 Mn |
| Dec 31, 2024 | -26.62 Mn |
| Sep 30, 2024 | -23.84 Mn |
| Sep 30, 2024 | -23.84 Mn |
| Jun 30, 2024 | -21.48 Mn |
| Jun 30, 2024 | -21.48 Mn |
| Mar 31, 2024 | -27.74 Mn |
| Mar 31, 2024 | -27.74 Mn |
| Dec 31, 2023 | -17.16 Mn |
| Dec 31, 2023 | -17.16 Mn |